Investing.com - Regeneron Pharma reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Regeneron Pharma announced earnings per share of $11.49 on revenue of $2.97B. Analysts polled by Investing.com EPS of $9.72 on revenue of $2.69B.
Regeneron Pharma 's are down 33.79% and is trading at $660.49 , still down 11.63% from its 52 week high of $747.42 set on Friday, April 8, 2022.
Regeneron Pharma follows other major Healthcare sector earnings this month
Regeneron Pharma's report follows an earnings beat by J&J on Tuesday, April 19, 2022, who reported EPS of $2.67 on revenue of $23.43B, EPS of $2.59 on revenue of $23.62B.
UnitedHealth had beat expectations on Thursday, April 14, 2022 with first quarter EPS of $5.49 on revenue of $80.15B, for EPS of $5.36 on revenue of $78.73B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar